glp 1 combination Effect of treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study GLP-1 single, dual, and triple

Metabolism 2025;163:156100.ArticlePubMed 79

assessed the relationship between GLP-1 RAs and severe hepatic complications through 88,371 individuals with type 2 diabetes

If your practice offers both weight-loss injections and lasers, your patients stay with the provider who understands their goals, not the one who only meets part of their needs

2023;38(suppl

[28,29] Furthermore, surgery is not considered the first line of treatment for everyone because it requires patients to meet the eligibility criteria, which include a BMI 40, the presence of one or more obesity-related comorbidities (heart disease, stroke, hypertension, and T2D), and the inability to maintain a healthy weight over time